Foundations Investment Advisors’s Achieve Life Sciences ACHV Stock Holding History

Foundations Investment Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$392K	Buy	+133,300	New	+$592K	﹤0.01%	803

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Foundations Investment Advisors's ACHV Position: Q1 2026 in Review

Foundations Investment Advisors opened a new position in Achieve Life Sciences (ACHV) in Q1 2026: 11,702 shares worth $34.4K. The stake represents ﹤0.01% of the portfolio and ranks #1154 among its holdings.

81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Foundations Investment Advisors held 11,702 shares of Achieve Life Sciences worth $34.4K as of Q1 2026.
Achieve Life Sciences was a new Foundations Investment Advisors position in Q1 2026.
Achieve Life Sciences made up ﹤0.01% of Foundations Investment Advisors's portfolio in Q1 2026, its #1154 holding.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Foundations Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.